RHRonald C. Hamaker

Ronald C. Hamaker

*This is an algorithmically generated author record based on publicly available information.

Ronald C. Hamaker has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Botulinum Neurotoxin for Pharyngeal Constrictor Muscle Spasm in Tracheoesophageal Voice Restoration

    by Ronald C. Hamaker, Eric D. Blom

    Objectives/Hypothesis The purpose of the study was to evaluate the effectiveness of Botulinum neurotoxin (Botox) for elimination of pharyngeal constrictor muscle spasm in tracheoesophageal voice restoration.Study Design A retrospective review was made of 62 patients between 1991 and 2002 who had Botox as the initial treatment for pharyngeal constrictor muscle spasm.Methods One hundred units of Botox properly diluted in 3 mL saline was instilled unilaterally under electromyographic guidance after fluoroscopic identification and marking of the contracted pharyngeal constrictor muscles. The patients were divided into three groups based on their response to the first Botox injection: group I, complete relaxation of the pharyngeal constrictors resulting in fluent voice, intratracheal phonation pressure of 20 to 40 cm H2O, and the ability to say 15 to 20 uninterrupted syllables; group II, hypertonic or incomplete relaxation of the pharyngeal constrictors resulting in intratracheal phonation pressure of 45 to 70 cm H2O and the ability to say 7 or 8 syllables; and group III, failure to produce relaxation of the pharyngeal constrictors.Results After the first injection of Botox, 49 (79%) patients were in group I or II (41 in group I and 8 in group II) and group III consisted of 13 patients. Thirty‐four patients (55%) had group I (28) or II (6) responses for greater than 6 months. A second Botox injection enabled 6 of the 13 failures to move into group I. In all, 8 pharyngeal constrictor muscle myotomies (13%) were ultimately required in the 62 patients. The group I speaker for the longest period has enjoyed 11 years of fluency and successful daily use of a tracheostoma valve after two Botox injections.Conclusion Botox relaxation of the pharyngeal constrictor muscles has proven to be effective, has replaced secondary pharyngeal myotomy for the initial treatment of pharyngeal muscle spasm, and is the only treatment in patients who are not candidates for elective surgery. Radiographic assessment, electromyographically monitored injection, and the number of Botox units appear to be important to successful outcomes.


  • Open Access

    Functional outcome after surgery for prevention of pharyngospasms in tracheoesophageal speakers. Part II: Swallow characteristics

    by Barbara Roa Pauloski, Jerilyn A. Logemann, Eric D. Blom, Ronald C. Hamaker

    The swallowing function of 29 patients with primary tracheoesophageal puncture who received either a pharyngeal constrictor myotomy, a unilateral pharyngeal plexus neurectomy, or a unilateral pharyngeal plexus neurectomy with a small drainage myotomy limited to the cricopharyngeus was studied. Swallowing function data were collected on each patient at 3 weeks, 6 months, and 12 months after surgery using videofluoroscopy. Differences in swallowing function among the treatment groups were primarily the amounts and loci of oral and pharyngeal residues. The differing patterns of bolus residue may reflect the different mechanisms that were affected by the various procedures. Despite significant changes in some swallow measures, the patients did not complain of dysphagia. Oropharyngoesophageal swallow efficiency--a clinical measure that weighs the amount of bolus swallowed by total transit time--fell within normal limits for each patient group at each evaluation. This measure may be a better index of the patients' perceived normal swallow than the component variables of residue and transit times would suggest.